Fast bodyweight training improves speed
- Trial ID
- NCT06646523
- Official Title
- Effects of Remotely Supervised Home-based High-speed Bodyweight Resistance Training on Bradykinesia in Individuals With Parkinson's Disease: A Randomized Clinical Trial
- Goal
- Fast bodyweight training improves speed
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Federal University of Minas Gerais
- Study Type
- INTERVENTIONAL
- Enrollment
- 46 participants
- Conditions
- Parkinson Disease
- Interventions
- High-speed bodyweight resistance training, Control group (Bodyweight intervention, usual speed)
Plain-Language Summary
The goal is to reduce bradykinesia, the slowness and reduced quickness in movement that makes daily tasks and walking harder for people with Parkinson's. The approach uses remotely supervised, home-based high-speed bodyweight resistance training, meaning fast, powerful bodyweight movements done under video coaching to train muscles and the nervous system to activate more quickly and produce greater movement speed, while the control group does the same exercises at a usual, slower pace; participants continue their regular antiparkinsonian meds. The trial is looking for people 50 or older with Parkinson's at Hoehn and Yahr stages 1,3 who have measurable bradykinesia, are on stable medication, are inactive or insufficiently active, can walk without assistive devices, have internet and a caregiver to assist, and do not have major cognitive or other medical issues or deep brain stimulation.
Locations
- Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
Frequently Asked Questions
- What is this trial testing?
- This trial is studying High-speed bodyweight resistance training. The goal is to reduce bradykinesia, the slowness and reduced quickness in movement that makes daily tasks and walking harder for people with Parkinson's. The approach uses remotely supervised, home-based high-speed bodyweight resistance training, meaning fast, powerful bodyweight movements done under video coaching to train muscles and the nervous system to activate more quickly and produce greater movement speed, while the control group does the same exercises at a usual, slower pace; participants continue their regular antiparkinsonian meds. The trial is looking for people 50 or older with Parkinson's at Hoehn and Yahr stages 1,3 who have measurable bradykinesia, are on stable medication, are inactive or insufficiently active, can walk without assistive devices, have internet and a caregiver to assist, and do not have major cognitive or other medical issues or deep brain stimulation.
- Who can participate?
- Participants must be at least 50 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 5 months.